Related references
Note: Only part of the references are listed.Do Epstein-Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?
Paul J. Farrell et al.
BIOMOLECULES (2022)
The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications
Adelaide Ohui Fierti et al.
BIOMOLECULES (2022)
Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer
Joseph A. Sparano et al.
NPJ BREAST CANCER (2022)
NOTCH expression variability and relapse of breast cancer in high-risk groups
José Damián Gómez-Archila et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2022)
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer
Tsvetalina Tankova et al.
CANCERS (2022)
Epstein-Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
Oren Shechter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
Kunrui Zhu et al.
CELLS (2022)
Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment
Fatma Nasser et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)
The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer
Ishita Gupta et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients
Zuzana Cierna et al.
SCIENTIFIC REPORTS (2021)
Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling
Fengjie Liu et al.
MEDIATORS OF INFLAMMATION (2021)
Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study
Rebekah L. Crake et al.
SCIENTIFIC REPORTS (2021)
Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation
Takayuki Murata et al.
VIRUSES-BASEL (2021)
Is EBV Associated with Breast Cancer in Specific Geographic Locations?
Alison J. Sinclair et al.
CANCERS (2021)
The regulation of microRNA in each of cancer stage from two different ethnicities as potential biomarker for breast cancer
Kevin Nathanael Ramanto et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2021)
Long non-coding RNAs in Epstein-Barr virus-related cancer
Yitong Liu et al.
CANCER CELL INTERNATIONAL (2021)
Role of Virus-Induced Host Cell Epigenetic Changes in Cancer
Valeria Pietropaolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer
Kotaro Azuma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Stress-Induced Epstein-Barr Virus Reactivation
Daniel G. Sausen et al.
BIOMOLECULES (2021)
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Jeffrey E. Gold et al.
PATHOGENS (2021)
Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors
Gift C. Nwagu et al.
JCO GLOBAL ONCOLOGY (2021)
Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study
Ya Cao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Epstein-Barr Virus Infection and Increased Sporadic Breast Carcinoma Risk: A Meta-Analysis
Qing'e Jin et al.
MEDICAL PRINCIPLES AND PRACTICE (2020)
The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis
Barbara Matyasi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes
Lei Wang et al.
EBIOMEDICINE (2020)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer
Zhong Wang et al.
CELL DEATH & DISEASE (2020)
Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016
Teofilia Acheampong et al.
JAMA NETWORK OPEN (2020)
Multiomic analysis of cytokines in immuno-oncology
Vladimir Jurisic
EXPERT REVIEW OF PROTEOMICS (2020)
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
Jianmin Hu et al.
THERANOSTICS (2020)
Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance
Longlong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans
Richmond Ayee et al.
JOURNAL OF CANCER (2020)
Epstein-Barr virus and risk of breast cancer: a systematic review and meta-analysis
Mohammad Farahmand et al.
FUTURE ONCOLOGY (2019)
A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses
Louise Zanella et al.
SCIENTIFIC REPORTS (2019)
The Function and Therapeutic Potential of Epstein-Barr Virus-Encoded MicroRNAs in Cancer
Man Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Genetic polymorphism of miRNA-196a and its target gene annexin-A1 expression based on ethnicity in Pakistani female breast cancer patients
Amena Rahim et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2019)
Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus
Nicholas A. Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer
Te-Chia Wu et al.
CANCER RESEARCH (2018)
Epstein-Barr virus-encoded microRNAs as regulators in host immune responses
Man Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups
Laura R. Wasil et al.
JOURNAL OF VIROLOGY (2018)
A tumor-myeloid cell axis, mediated via the cytokines IL-1α and TSLP, promotes the progression of breast cancer
Emma L. Kuan et al.
NATURE IMMUNOLOGY (2018)
Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus
Jia Chen et al.
NATURE MICROBIOLOGY (2018)
Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
Maria K. Smatti et al.
FRONTIERS IN ONCOLOGY (2018)
Epstein-Barr Virus and Human Papillomaviruses Interactions and Their Roles in the Initiation of Epithelial-Mesenchymal Transition and Cancer Progression
Farhan S. Cyprian et al.
FRONTIERS IN ONCOLOGY (2018)
Reactivation of Latent Epstein-Barr Virus: A Comparison after Exposure to Gamma, Proton, Carbon, and Iron Radiation
Satish K. Mehta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes
Stine L. Figenschau et al.
SCIENTIFIC REPORTS (2018)
Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
Ahmed El-Sharkawy et al.
FRONTIERS IN ONCOLOGY (2018)
The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets
Mujeeb R. Cheerathodi et al.
FUTURE VIROLOGY (2018)
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1
Michael Hulse et al.
PLOS PATHOGENS (2018)
Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants
Sumit Siddharth et al.
CANCERS (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
Weilong Chen et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer
Wasifa Naushad et al.
INFECTION GENETICS AND EVOLUTION (2017)
Heterogeneity of the Epstein-Barr Virus (EBV) Major Internal Repeat Reveals Evolutionary Mechanisms of EBV and a Functional Defect in the Prototype EBV Strain B95-8
Mohammed M. Ba Abdullah et al.
JOURNAL OF VIROLOGY (2017)
Association of Epstein - Barr virus and breast cancer in Eritrea
Ghimja Fessahaye et al.
INFECTIOUS AGENTS AND CANCER (2017)
Relationship between Epstein-Barr virus and cancer development
Angela Patricia Medina-Ortega et al.
IATREIA (2017)
Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns
Amanda L. Treece et al.
LABORATORY INVESTIGATION (2016)
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103
Baoyu He et al.
CELL DEATH & DISEASE (2016)
Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection
Anne L. Palser et al.
JOURNAL OF VIROLOGY (2015)
Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study
Tahar Aboulkassim et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Epstein-Barr virus latent genes
Myung-Soo Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Epstein-Barr virus latent membrane protein-2A alters mitochondrial dynamics promoting cellular migration mediated by Notch signaling pathway
Anindita Deb Pal et al.
CARCINOGENESIS (2014)
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Enrique A. Mesri et al.
CELL HOST & MICROBE (2014)
Prevalence of Papillomaviruses, Polyomaviruses, and Herpesviruses in Triple-Negative and Inflammatory Breast Tumors from Algeria Compared with Other Types of Breast Cancer Tumors
Marilys Corbex et al.
PLOS ONE (2014)
Epstein Barr virus entry; kissing and conjugation
Claire Shannon-Lowe et al.
CURRENT OPINION IN VIROLOGY (2014)
Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
Sherif A. Ibrahim et al.
PLOS ONE (2013)
Epstein-Barr Virus_Encoded LMP1 Upregulates MicroRNA-21 to Promote the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin-Induced Apoptosis by Suppressing PDCD4 and Fas-L
Guang-Da Yang et al.
PLOS ONE (2013)
No association between Epstein-Barr Virus and Mouse Mammary Tumor Virus with Breast Cancer in Mexican Women
Abigail Morales-Sanchez et al.
SCIENTIFIC REPORTS (2013)
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
Alexander Pedroza-Gonzalez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection
Claire Shannon-Lowe et al.
PLOS PATHOGENS (2011)
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
David G. DeNardo et al.
CANCER CELL (2009)
Toll-like receptors, wound healing, and carcinogenesis
Johannes Kluwe et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Growth-Promoting Properties of Epstein-Barr Virus EBER-1 RNA Correlate with Ribosomal Protein L22 Binding
Jennifer L. Houmani et al.
JOURNAL OF VIROLOGY (2009)
Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification
Claire Shannon-Lowe et al.
JOURNAL OF VIROLOGY (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines
Zachary L. Pratt et al.
VIROLOGY (2009)
An auto-regulatory loop for EBV LMP2A involves activation of Notch
Leah J. Anderson et al.
VIROLOGY (2008)
Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells
Jiun-Han Lin et al.
JOURNAL OF VIROLOGY (2007)
A molecular link between malaria and Epstein-Barr virus reactivation
Arnaud Chene et al.
PLOS PATHOGENS (2007)
Relationship between viral factors, axillary lymph node status and survival in breast cancer
Ju-Hsin Tsai et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type IIFN
Mrinal Samanta et al.
EMBO JOURNAL (2006)
Clinical presentation and natural course of hepatocellular carcinoma
ES Bialecki et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues
JH Tsai et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
SM Tugizov et al.
NATURE MEDICINE (2003)
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
O Hermine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes
U Zimber-Strobl et al.
SEMINARS IN CANCER BIOLOGY (2001)
Share Paper
